Julian Hickling Selected Research

Herpes Simplex Virus Vaccines

11/2019

Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julian Hickling Research Topics

Disease

2	Infections 11/2019 - 11/2015
2	Neoplasms (Cancer) 09/2003 - 12/2002
2	Vaccinia 09/2003 - 12/2002
1	Measles 11/2023
1	Rubella (German Measles) 11/2023
1	Neonatal herpes 11/2019
1	Belonephobia 01/2018
1	Needlestick Injuries (Needlestick Injury) 01/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2002

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 11/2023 - 12/2002
2	Proteins (Proteins, Gene)FDA Link 09/2003 - 12/2002
1	Neutralizing AntibodiesIBA 11/2023
1	rubella antibodiesIBA 11/2023
1	Rubella VaccineIBA 11/2023
1	Herpes Simplex Virus VaccinesIBA 11/2019
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2015
1	EnzymesIBA 09/2003
1	Peptides (Polypeptides)IBA 09/2003
1	AntibodiesIBA 09/2003
1	Oncogene Proteins (Oncogene Protein)IBA 09/2003
1	Glutathione Transferase (Glutathione S-Transferase)IBA 09/2003
1	Viral ProteinsIBA 12/2002
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2002
1	AntigensIBA 12/2002

Therapy/Procedure

1	Immunotherapy 09/2003
1	Hysterectomy 12/2002